chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Her left arm was itching and hurting; arm was hurting; was red; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Her left arm was itching and hurting), VACCINATION SITE PAIN (arm was hurting), VACCINATION SITE ERYTHEMA (was red), CHILLS (chills) and PYREXIA (fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder, Fluid retention and Sinus pain. Concomitant products included TORSEMIDE for Fluid retention, POTASSIUM, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN (MUCINEX DM) for an unknown indication.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 23-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Her left arm was itching and hurting), VACCINATION SITE PAIN (arm was hurting), VACCINATION SITE ERYTHEMA (was red), CHILLS (chills) and PYREXIA (fever). On 25-Jan-2021, VACCINATION SITE PRURITUS (Her left arm was itching and hurting), VACCINATION SITE PAIN (arm was hurting), VACCINATION SITE ERYTHEMA (was red), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Zyrtec; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. The reported events are consistent with the product safety profile
I felt like I had a really bad head cold. It started with a scratchy throat on Saturday. By Thursday, I was feeling better enough so that I was able to clean the house on Friday. I just felt like for 2 and a half days, I felt constantly like I was going to sneeze. Felt like on the verge of sneezing and nothing happening. Felt like the head cold. I do have some residual drainage but feeling pretty good right now. Out of isolation.
Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; Experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days; This is a spontaneous report from a contactable Nurse (patient). This 41-Year-old female Nurse (no pregnant) received first dose of BNT162B2 (Lot number: EJ1685) on 04Jan2021 09:00 AM on Left arm for COVID-19 immunization. Medical history was migraines. Concomitant drug was not reported. Known allergies: amoxicillin, cefaclor (CECLOR), ciprofloxacin hydrochloride (CIPRO), erythromycin, Zithromax. Patient experienced extreme nausea, moderate diarrhea, moderate fatigue, mild headache, fever of 38, hot flashes/chills, body aches, general malaise and very mild injection site soreness in the hours and days following injection on 05Jan2021 00:30 (reported as 04Jan2021 12:30 PM) with outcome was recovering. Treatment: Medication for nausea (zofran). Covid test post vaccination on 06Jan2021, result unknown. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Not any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19.  Follow-up attempt are not possible. No expected further information.
A report has been received from a physician via medical rep. concerning a 10 year old female patient. Follow up received from health professional. No information regarding relevant history, concurrent disease and concomitant medications of the patient was provided. The patient has been receiving FLUMIST QUADRIVALENT (intranasal), unknown frequency, started on 09-Oct-2014 for an unknown indication. It was reported that a 10 year old girl had a nosebleed after insertion of the FLUMIST syringe into the first nostril 09-Oct-2014. Lot Number was CH2063. The nurse said that the patient's nose stopped bleeding right after the FLUMIST was given into the first nostril. They did not administer the second dose into the other nostril. Action taken with FLUMIST QUADRIVALENT was unknown. The patient recovered from the event of nosebleed on an unspecified date. The reporter considered the event of nosebleed to be non-serious.
I contracted COVID-19 on 10/20/22 with symptoms of headache, sore throat, laryngitis, fever, cough, and congestion. I was prescribed PAXLOVID on 10/22/22. I was ill for 5 days before my symptoms began to abate. I am still experiencing a lingering cough and sore throat.
PT EXPERIENCED BRUISE INFLAMMATION AND PAIN AT SOURCE OF INJECTION AND DOWN THE ARM. POSSIBLE LEAK OF VACCINATION TO MUSCLE. LASTED SEVERAL DAYS. NO SIGN OR SYMPTOMS PERSISTED. THERE WERE NO VISIBLE SIGNS AND PATIENT SAID THE ARM DID NOT HURT ANYMORE. POSSIBLE. NO TREATMENT WAS DISCUSSED. AND PT WAS OK AND CLEAR ON 7/29/16.
tingling @ inject site & feeling of vax migrating are reported in a pt receiving 1 dose of flu vax;
Mother reports within 2.5 hours of vaccination patient experienced sudden and severe onset of headache, muscle aches, and fatigue. She also reported having trouble moving her legs but was able to walk independently. Symptoms reportedly resolved by 11/23/18 however patient was in bed for several days following onset of event. Mother reports fever of 100.3 during course of event.
A 4 year old boy developed a fever after receiving his third RabAvert immunization. The mother of the pt described finding the child holding a bat, that later tested positive for rabies. On 03May04, the pt started post exposure prophylaxis therapy. Eight hours after the third immunization with RabAvert, the pt developed a fever 99.8 F, vomited once and complained of a stiff neck. The pt was taken to ER, where a complete blood count was drawn, analyzed and found to be normal. He was released home. Later the mother remembered she had forgotten to give the pt Tylenol after the third immunization, which she had done previously for the first two immunizations. In addition, she realized the pt had fallen asleep in his father's lap in a strange position and awakened with a complaint of a stiff neck. Follow up received 21May04: The pt is doing fine. He is scheduled for his final vaccination 28May04. Follow up received 18Oct04: The mother reported additional events of lethargy, sore neck and described the previously reported fever as high temperature. The lot number was provided. The date of 03May04 of the first RabAvert injection could not be verified.
Patient has injection site reaction with red raised rash.  Patient also had a low fever and muscle and body aches.  Patient states fever and muscle/body aches lasted one day, but rash remains.
Pt given expired vaccine. Moderna contacted and recommended to repeat dose. Patient contact and asked to return to clinic
Called patient to remind them that 2nd dose is due.  This was the first time notified by patient that he had a reaction the day after 1st dose.  He had a rash on his hand and was unable to feel or move his arm.  He was admitted to the hospital.  Length of hospital stay not known. Patient has recovered since then.
Upper arm where the shot was given was sore; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if prior to the vaccination, the patient was diagnosed with COVID-19. On 04Mar2021, the patient experienced that the upper arm where the shot was given was sore for about 2 to 3 days. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if therapeutic measures were taken as a result of the event. It was unknown if since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event sore upper arm where the shot was given was recovered on an unspecified date in Mar2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse concerning a 25 year old female who on 16-JUL-2008 was vaccinated with the first dose of GARDASIL IM (lot # not reported). On 16-JUL-2008 the patient fainted almost immediately after receiving vaccine. The patient took a little longer to come out of it than what they have seen in the past. Subsequently, the patient recovered from fainted immediately after receiving vaccine. The patient sought medical attention. Additional information has been requested.
New admission from E.R., recieved Pneumovax in ER, c/o R tricep swelling, pain, itching, observed swelling, edema, warmth, redness, notified Dr., ordered Benadryl 25mg po x1, administered Bbenadryl and placed cold pack on arm.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 06-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Pt received PNEUMOVAX and H1N1 vaccines on 11/9/09. Later that evening, developed swelling of arm, fever of 103 degrees, headache and malaise. Pt has rheumatoid arthritis and lupus and is on immune suppressants.
fever of 100.83; left arm pain; very slight swelling; This is a spontaneous report from a contactable consumer (patient) via regulatory authority. A 50-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 11Mar2021 16:30 (lot number: EN6199; expiry date: unknown) at the age of 50-years-old, as dose 1, single for Covid-19 immunisation. Medical history included Covid-19 (COVID prior vaccination: Yes) and arthritis (possible rheumatoid waiting for rheumatologist appointment). The patient was taking unspecified concomitant medications. The patient was not pregnant at the time of vaccination. The patient did not receive other vaccines four weeks prior vaccination. The patient previously took morphine and experienced allergies (known allergies: sensitive to morphine). On 12Mar2021, at 10 am, the patient experienced fever of 100.83, left arm pain, and very slight swelling. The patient did not receive treatment for the events. The patient underwent lab tests and procedures which included body temperature: 100.83 on 12Mar2021. Outcome of the events was unknown. The patient has not been tested for COVID-19 post vaccination.  No follow-up attempts are possible. No further information is expected.
Itching and soreness at injection site 03/07/2021 Arthritis pain worse than usual 03/07/2021 Nausea 03/07/2021 Fatigue 03/07/2021
EE developed diarrhea in afternoon, then migraine headache, fever and blurred vision.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history and drug reactions or allergies were not reported. On unknown dates, the patients were inadvertently vaccinated with improperly stored doses of PROQUAD (Merck) (dose and route were not reported, lot # L024123, expiry date 30-DEC-2016; lot # L010141, expiry date 24-SEP-2016). Concomitant medications were not reported. No adverse reactions were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Had Flushot 10/4/2010 had immediate pain in (R) arm + hurts down to forearm. 11/2 after pain seems to be getting worse.
Pfizer Dose 1: 7/16/2021 EW0180 Pfizer Dose 2: 8/6/2021 EW0178 My son woke on 8/15/2021 describing a weird dream and waking experience he had. It only lasted 1-2 minutes where he described a dream he was having but was starting to wake up from it. On 08/19/2021, he had an almost 10 minute episode upon waking where he could not move his body though he was awake.  At first his hands were clammy and the fingers had to be pried open. Over that time he slowly began to move his fingers and toes. He was terrified. We made a doctor's appointment that same day.
TOOK BROKEN CAPSULE; This spontaneous case (PVX2019-1545, PTC-000064) was received from a pharmacist on 14-Jun-2019. It describes a 36-year-old adult female consumer who "took broken capsule". The consumer was receiving oral Vivotif (one capsule every other day) (lot number: 3003277 and expiry date: May 2020) for typhoid prophylaxis.  Case report: The consumer found that one capsule of Vivotif inside the pack was broken and the powder spread out of it but she took that broken capsule on 14-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took broken capsule" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took broken capsule" was considered as not applicable.
experienced a rash; This spontaneous report was received from a medical assistant and refers to a currently 3-year-old female patient. The patient did not have any pertinent medical history or drug reaction and allergies. No information regarding the patient's concomitant medications was reported.   On 18-DEC-2017, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) lot # N014483, expiry date 10-MAY-2019, subcutaneously (dose and vaccination site were not specified) which was reconstituted with sterile diluent for prophylaxis.   On an unknown date, after receiving the vaccine on 18-DEC-2017, the patient experienced a rash. The patient sought medical attention in a physician's office. Lab diagnostics were not performed. The patient recovered from the event on an unknown date. The causality assessment was not provided.
As patient was leaving, felt nauseous. Brought patient back into room. Very pale, diaphoretic, BP 73/44, hr 63. States her ears were ringing. Laid down for 20 more minutes, juice box given and finished. Ear ringing resolved, patient's color much improved. BP 88/59, HR 59. BP at 11:25 90/64 HR 65. Patient standing and walking with no issues. States feels much better. Left with mother.
My second dose was 5/31/21 in which I broke out into daily hives ever since. I was diagnosed with CIU which got triggered by the vaccine. I have taken daily benedryl since then to keep the hives at bay. Now on 12/13/21 I got my booster, and my hives are absolutely insane and are no longer being kept at bay with the benedryl. I woke up the pst two mornings with my entire back, legs, and head covered in large welts. I am a part of a support group for CIU and several people have claimed to have significantly worsening symptoms after the vaccine was administered. I am still glad I got the vaccine, but I do hope this is looked into as a side effect.
lightheaded, slightly dizzy immediately.  had hard time breathing and my inhaler did not help.  this lasted  until about 7:00 p.m. the following night.  By 3rd day I felt much better.
The patient is a 59 yo male with a history of ALS, ventilator dependent who developed acute pancreatitis with illness onset 5 days after receipt of Shingrix #2 from VA visiting nurse via Home Based Primary Care.  He had fever the following day with temp 100.2 , but symptoms resolved by next day and he resumed baseline wellness. On day 5 wife noticed cold sweats, lowered pulse oximetry and increased blood sugars. He continued to decompensate with increased blood glucose in 300 range, decreased LOC, inability to communicate and was brought to ER by POC 01 FEB (check in 09:35) for evaluation. the patient was hyperglycemia,  WBC 18, h/h 8/23, + serum ketones . He was admitted with hyperglycemia, leukocytosis and anemia. Discharged on day 10 with hospital dx proteocaloric deficiency, DM with hyperglycemia, genital edema, constipation, sinus tachycardia, small left pneumothorax, hypoproliferative anemia, anxiety, hypernatremia, and pancreatitis. Vaccine documentation not available.
It was reported that a pt (4 of 5) received a Fluzone SV '00 - '0 vaccination. Reportedly sometime after the vaccination the pt developed a local reaction of redness and warmth. No specifics provided, further information is requested.
Reporting patient received 2 doses in less than the time frame of every 10 years. Pt did not report any adverse reaction. notifying of vaccination error.
diagnosed with COVID in May/had a sore throat; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (diagnosed with COVID in May/had a sore throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026D21A, 030M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2022, the patient experienced COVID-19 (diagnosed with COVID in May/had a sore throat). At the time of the report, COVID-19 (diagnosed with COVID in May/had a sore throat) outcome was unknown.            No Concomitant product use was reported.  The reporter was reporting on behalf of their husband who was the patient. The patient received the first booster on 23-Oct-2021. The reporter stated that the patient was diagnosed with COVID in May and also mentioned that the patient had a sore throat.  No treatment information was provided.  Company Comment:  This is a spontaneous case concerning  a male patient of unknown age, with no reported medical history, who experienced the unexpected non-serious AESI event of Covid-19. The event occurred on an unspecified day of May 2022, day after the third dose of mRNA-1273 COVID 19 Vaccine which was administered on October 23, 2021. The event outcome was reported as unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.; Sender's Comments: Company Comment:  This is a spontaneous case concerning  a male patient of unknown age, with no reported medical history, who experienced the unexpected non-serious AESI event of Covid-19. The event occurred on an unspecified day of May 2022, day after the third dose of mRNA-1273 COVID 19 Vaccine which was administered on October 23, 2021. The event outcome was reported as unknown. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.
Nurse documented that a Hepatitis A adult formulation was administered when a pediatric/adolescent dose should have been given.
Parasthesia (Numbness and tingling) to left leg. ER visit. Blood tests performed. Symptoms lasted 2 days then subsided, but numbness still present.
"COVID Arm" - large circular rash on right arm, injection site. Slightly itchy in that area. Swollen lymph node in armpit of that same arm. Fatigue, headache.
Erectile dysfunction long term unfortunately with sac reduction; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in arm on 11Jun2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient had unspecified medical history and unspecified concomitant drugs. Patient did not receive other vaccine in four weeks. Patient did not have COVID-19 prior to vaccination. Patient had no known allergies. The patient experienced erectile dysfunction long term (erectile dysfunction: disability, medically significant; scrotal disorder: disability) on 14Jun2021 with outcome of not recovered. No therapeutic measures were taken as a result of the events. Patient did not tested for COVID-19 post vaccination.  The lot number for bnt162b2 was not provided and will be requested during follow-up.
Urticaria lower face, a few additional isolated lesions on ears, wrist, leg. Information from medical record states allergic reaction. msv
Dad called 6/28/05 right arm swelling no fever. Cold compress with Motrin and RTC 6/29/05. 6/30/05 12P per dad, child doing better.
Severe Muscle aches all over the body, chills, increased temperature without fever, severe headache, nausea, dehydration, nose congestion, sharp needle pain on various areas of body, sore arm
fever of 103; Headache; Low oxygen level; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever of 103), HEADACHE (Headache) and OXYGEN SATURATION DECREASED (Low oxygen level) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 044B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced PYREXIA (fever of 103), HEADACHE (Headache) and OXYGEN SATURATION DECREASED (Low oxygen level). At the time of the report, PYREXIA (fever of 103), HEADACHE (Headache) and OXYGEN SATURATION DECREASED (Low oxygen level) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-211427 (Patient Link).